Glenmede Trust CO Na Esperion Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$25.12 - $36.89 $202,743 - $297,739	-8,071 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $99,704 - $147,331	-4,120 Reduced 33.8%	8,071 $209,000
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $95,410 - $161,292	3,060 Added 33.51%	12,191 $453,000
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $31,992 - $54,645	-1,065 Reduced 10.45%	9,131 $468,000
Q4 2019 Feb 12, 2020	BUY	$35.4 - $59.82 $360,938 - $609,924	10,196 New	10,196 $607,000

199

136M

2.72M

1.3M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $112M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.